Ikarian Capital, LLC Aclaris Therapeutics, Inc. Call Options Transaction History

Ikarian Capital, LLC

  • $247 Million
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.56 - $10.95 $23,858 - $39,825
3,637 New
3,637 $24,000
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $4.17 Million - $10.6 Million
589,300 New
589,300 $4.77 Million
Q4 2020

Feb 12, 2021
BUY
$2.65 - $7.61 $624,870 - $1.79 Million
235,800 New
235,800 $1.53 Million

Others Institutions Holding ACRS

# of Institutions
97
Shares Held
52.4M
Call Options Held
32.4K
Put Options Held
3.3K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email